ISIS-333611
- Generic Name
- ISIS-333611
- Drug Type
- Biotech
- CAS Number
- 937407-37-9
- Unique Ingredient Identifier
- 5QY760I44W
Safety, Tolerability, and Activity Study of ISIS SOD1Rx to Treat Familial Amyotrophic Lateral Sclerosis (ALS) Caused by SOD1 Gene Mutations
- First Posted Date
- 2009-12-31
- Last Posted Date
- 2012-04-13
- Lead Sponsor
- Ionis Pharmaceuticals, Inc.
- Target Recruit Count
- 33
- Registration Number
- NCT01041222
- Locations
- 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States
🇺🇸Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸Methodist Neurological Institute, Houston, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath